心内科房颤患者抗凝治疗的临床效果研究-国际临床研究杂志-CSCIED科技核心评价数据库-手机版

心内科房颤患者抗凝治疗的临床效果研究

Clinical effect of anticoagulation therapy in patients with atrial fibrillation in the Department of Cardiology

ES评分 0 浏览量：623 下载量：0

DOI	10.12208/j.ijcr.20220085
刊名	国际临床研究杂志 International Journal of Clinical Research
年，卷(期)	2022, 6(2)
作者	王秋菊*,
作者单位	兴安盟人民医院内蒙古兴安盟 ;
摘要	心内科房颤患者抗凝治疗的临床效果研究。方法自2021年度1月至2021年12月选择84例因房颤而就诊于我科室的病人进行调研，按照治疗举措将其归纳为2个小组，每组均纳入42例病人。按照治疗手段，将其命名为常规组与调研组。常规组在本次调研中所采用的治疗方案为阿司匹林单纯治疗，调研组在本次调研中所采用的治疗方案为法华林治疗。总结与探究2种治疗方案实施效果。结果经过治疗常规组与调研组血小板分布宽度、血小板水平、凝血酶原时间、D-二聚体均有所改善，常规组与治疗前相比血小板分布宽度降低、血小板水平降低、凝血酶原时间提高、D-二聚体降低，与治疗前相比，组间有一定差异，（P<0.05）；调研组与治疗前相比血小板分布宽度降低、血小板水平降低、凝血酶原时间提高、D-二聚体降低，与治疗前相比，组间有一定差异，（P<0.05）。虽然经过治疗，常规组与调研组指标水平改善，是常规组和调研组在比较，血小板水平高于调研组、凝血酶原时间低于调研组、D-二聚体高于调研组，两组对照，差异明显，（P<0.05）。结论房颤治疗中法华林抗凝治疗效果优异，此方案值得临床应用与普及。
Abstract	Objective: To study the clinical effect of anticoagulation in patients with atrial fibrillation in the department of cardiology. Methods From January 2021 to December 2021, 84 patients who were admitted to our department due to atrial fibrillation were selected for investigation. They were divided into 2 groups according to the treatment measures, and each group included 42 patients. According to the treatment methods, they were named as routine group and investigation group. The treatment plan adopted by the routine group in this investigation was aspirin alone, and the treatment plan adopted by the investigation group in this investigation was warfarin treatment. Summarize and explore the implementation effect of the two treatment programs. Results After treatment, the platelet distribution width, platelet level, prothrombin time, and D-dimer in the routine group and the investigation group were improved. Compared with before treatment, the routine group decreased platelet distribution width, platelet level, and prothrombin time. Compared with before treatment, there was a certain difference between the groups (P<0.05). Compared with before treatment, the investigation group decreased platelet distribution width, decreased platelet level, increased prothrombin time, and increased D-dimer. -Dimer decreased, compared with before treatment, there was a certain difference between groups (P<0.05). Although after treatment, the index levels of the routine group and the investigation group improved, which is the comparison between the routine group and the investigation group. The level of platelets was higher than that of the investigation group, the prothrombin time was lower than that of the investigation group, and the D-dimer was higher than that of the investigation group. , the difference was significant, (P<0.05). Conclusion Warlin anticoagulation has an excellent effect in the treatment of atrial fibrillation, and this program is worthy of clinical application and popularization.
关键词	心内科；房颤；抗凝治疗
KeyWord	Cardiology Department; Atrial Fibrillation; Anticoagulation Therapy
基金项目
页码	178-181

参考文献
相关文献

[1] 夏东升. 口服华法林抗凝治疗永久性房颤的疗效分析[J]. 系统医学,2017,2(10):53-55. DOI:10.19368/j.cnki.2096-1782.2017.10.053.

[2] 张华弟,王楚林,倪伟欣,等. 利伐沙班与华法林对房颤患者的抗凝有效性及安全性比较[J]. 中外医学研究,2021,19(19):4-6.DOI:10.14033/j.cnki.cfmr.2021.19.002.

[3] 陈敬强. 利伐沙班、华法林防治房颤患者脑卒中的效果对比[J]. 药品评价,2019,16(17):17-18. DOI:10.3969/j.issn.1672-2809.2019.17.008.

[4] 陶爱伟,倪水妹,费杏珍. 医院-社区-家庭无缝隙管理模式在房颤患者服用华法林期间的应用研究[J]. 护士进修杂志,2018,33(7):661-663. DOI:10.16821/j.cnki.hsjx.2018.07.027.

[5] 肖春晖,胡小李,汪玉龙,等. 小剂量递增法华法林治疗在高龄永久性心房颤动患者抗凝治疗中的作用[J]. 中国基层医药,2012,19(15):2339-2340. DOI:10.3760/cma.j.issn.1008-6706.2012.15.062.

[6] 成彦,顾宁,陈伟,等. 稳心律合剂对房颤大鼠3种血栓前标志物CD62p、D2D、VWF影响的研究[J]. 贵州医药,2017,41(3):239-241. DOI:10.3969/j.issn.1000-744X.2017.03.004.

[7] 江云东,杨思进,白雪,等. 新型抗凝药达比加群酯对高龄持续性房颤导管射频消融术围术期的抗凝疗效及安全性评价[J]. 中国新药与临床杂志,2015,34(9):671-675. DOI:10.14109/j.cnki.xyylc.2015.09.006.

引用本文

王秋菊*. 心内科房颤患者抗凝治疗的临床效果研究 [J]. 国际临床研究杂志. 2022; 6; (2). 178 - 181.

文献评论

相关学者

相关机构